Questions to Ask Your Radiation Oncologist Before Choosing Brachytherapy

The printout sits on the kitchen table, folded twice, with the word “brachytherapy” underlined in blue pen. Beside it is a list that started as three questions and has grown overnight to fourteen, several crossed out and rewritten. The appointment is on Thursday. Twenty minutes, maybe thirty, with the radiation oncologist, and a decision that feels much larger than that window of time.

This is the moment most people reach: not confused exactly, but short of the right vocabulary. The internet offers forums, a handful of hospital leaflets and a lot of confident strangers. What it rarely offers is a way to sort the questions to ask about brachytherapy from the ones that only sound important.

This article is that sorting tool. It explains what the treatment actually involves, where the evidence is firm and where it is not, and which questions tend to change the conversation in the consulting room.

How does brachytherapy work, in plain language?

Brachytherapy is internal radiation: a sealed radioactive source is placed inside or directly beside a tumor, rather than beamed in from a machine across the room. The Greek root “brachy” means short, and that is the whole idea. Radiation dose falls away steeply with distance, so a source sitting millimeters from cancer cells can deliver a high dose to them while the dose to tissue a few centimeters away drops sharply.

Picture a lamp. A reading lamp on your desk lights the page intensely and leaves the far corner of the room dim. External beam radiotherapy is closer to a floodlight that must pass through the whole room to reach the page. Both can work well; they simply spread light differently.

The source itself is usually a tiny metal seed or a pellet attached to a cable. It reaches the tumor through one of three routes, described by the National Cancer Institute and Mayo Clinic:

• Interstitial: thin needles or tubes placed directly into the tissue, as in prostate or breast brachytherapy.
• Intracavitary: an applicator placed in a natural body cavity, as in cervical or endometrial brachytherapy.
• Surface or intraluminal: a mold on the skin or a tube within an airway or the esophagus, used less often.

Planning happens before any radiation is delivered. Imaging such as CT, MRI or ultrasound maps the tumor and the organs next to it, and physicists calculate how long the source should sit at each position. In practice, the “treatment” you feel is the placement of applicators; the radiation itself is painless and invisible.

Why does this matter for your questions? Because almost every trade-off you will discuss, from side effects to session counts, comes back to one variable: how close the source sits to healthy tissue, and for how long.

Which questions to ask about brachytherapy matter most?

Not all questions carry equal weight. Some change the plan; others only change your comfort with it, which still matters, but in a different way. A useful habit is to divide your list into three groups before the appointment.

The first group concerns fit. Why brachytherapy for this cancer, at this stage, in this body? What does my imaging show about the tumor’s size and position that makes internal radiation suitable? Would you recommend the same approach if I were your family member, and what would make you hesitate? These questions reveal whether brachytherapy is a strong candidate or one option among several.

The second group concerns mechanics. Is this high dose rate or low dose rate? How many sessions, over what period? Will I be asleep, sedated or awake? Will I stay overnight? Is brachytherapy the entire plan, or a boost added to external beam radiotherapy, hormonal therapy or surgery?

The third group concerns consequences. Which side effects are most common in the first weeks, which can appear years later, and what does the team do to reduce each one? What precautions apply at home? How and when will you check whether the treatment is working?

Here is an opinion, grounded in the guidance from Mayo Clinic and the National Cancer Institute: the single most valuable question is often the plainest one. “What are the alternatives, and why do you prefer this one for me?” A good radiation oncologist will answer it without defensiveness, name the uncertainty honestly, and welcome a second opinion if you want one.

Write the answers down, or ask whether you can record the conversation. Memory under stress is unreliable, and the details you will want later are exactly the ones that slip away first.

HDR vs LDR brachytherapy: what to ask about each

Two broad methods exist, and the difference shapes almost everything else you will experience. High dose rate (HDR) brachytherapy delivers radiation from a powerful source for minutes at a time, then the source is withdrawn; nothing radioactive stays in the body. Low dose rate (LDR) brachytherapy uses weaker sources that remain in place for hours, days or permanently, releasing radiation slowly as they decay.

Feature	High dose rate (HDR)	Low dose rate (LDR)
Source stays in body?	No, removed after each session	Temporary (hours to days) or permanent seeds
Typical session length	Minutes of radiation per session	Continuous over hours to days, or gradual decay over weeks to months
Hospital stay	Often outpatient, sometimes overnight	Temporary LDR may need an inpatient stay; permanent seeds usually same-day
Radiation precautions afterward	None, once source is removed	Precautions for a period your team specifies
Common uses	Cervical, endometrial, prostate, breast, skin	Prostate seeds, some eye and gynecologic cancers

According to the National Cancer Institute and Mayo Clinic, both methods are established and the choice depends on cancer type, tumor size, your anatomy and the center’s expertise, not on one being universally better. With permanent seeds, radioactivity fades over weeks to months depending on the isotope used, which is why precaution periods vary.

Questions worth asking: Why HDR or LDR for me? If permanent seeds, which isotope, and how long will my precautions last? If HDR, how many sessions, and will the applicator stay in place between them? Does the center offer both methods, and if not, would the recommendation change at a center that does?

Who is brachytherapy usually for, and who is usually asked to wait?

Brachytherapy suits cancers that are reachable and contained. The National Cancer Institute lists prostate, cervical, endometrial, breast, skin, head and neck, esophageal, lung, rectal and eye cancers among its common uses. Within each of those, selection is specific to the tumor and the person.

For prostate cancer, MedlinePlus explains that seed brachytherapy is generally considered for cancer that has not spread beyond the prostate, typically in lower- or intermediate-risk disease, sometimes combined with external beam radiotherapy or hormonal treatment for higher-risk cases. A very large prostate, significant pre-existing urinary obstruction or earlier prostate surgery can make seed placement harder, and your team may suggest another route or a preparatory step first.

For cervical cancer, brachytherapy is a standard component of treatment for locally advanced disease, usually following external beam radiotherapy with chemotherapy. Here the question is rarely whether, but when and how many sessions.

Who is usually asked to wait, or offered something else?

• People whose cancer has spread to distant sites, where a localized treatment addresses only part of the problem.
• Anyone with an active infection, uncontrolled bleeding risk or a condition that makes anesthesia unsafe, until that is managed.
• Those whose tumor sits too close to a critical structure for the planned dose to be delivered safely.
• People who have not yet completed a planned course of external beam therapy, since sequencing matters.

Ask directly: “What about my case makes me a candidate, and what would have made you say no?” The second half of that question often teaches you more than the first. Ask too whether any step, such as a bowel preparation, a pause in a blood-thinning medicine or a urinary assessment, must happen before you are ready. Those decisions sit with your treating team and, where medicines are involved, with the clinician who prescribed them.

Questions to ask about brachytherapy versus surgery or external radiotherapy

Few people are offered brachytherapy in isolation. Prostate cancer in particular may come with three or more reasonable pathways, and the NHS prostate cancer guidance is candid that treatment choice often depends on the balance of side effects a person is prepared to accept, because several options are considered appropriate for localized disease.

Useful comparison questions include:

• For my cancer, how do surgery, external beam radiotherapy and brachytherapy differ in the side effects I am most concerned about: urinary, bowel, sexual or cosmetic?
• Which option keeps the most doors open if the cancer returns?
• How many visits does each option require, and over how many weeks?
• What would you need to see on imaging or biopsy to change your recommendation?
• Is active surveillance a reasonable choice for me, and if so, what would prompt a move to treatment?

A fair comparison acknowledges what the evidence does and does not show. Head-to-head trials between modalities are fewer than people assume, and results from large cohorts can reflect how patients were selected as much as how well a treatment works. When an oncologist says “the data are mixed,” that is honesty, not evasion.

Notice, too, how the answer to “how many visits” shapes daily life. External beam radiotherapy commonly runs daily on weekdays for several weeks, the NHS notes, whereas brachytherapy compresses treatment into a handful of sessions or a single procedure. For someone with a long commute, a job without leave or caring responsibilities, that difference is not trivial. Ask about it without apology.

Resist the urge to rank options by what a friend chose. Their tumor, their anatomy and their priorities were not yours.

What actually happens on treatment day?

The sequence is more predictable than people expect, and knowing it removes a surprising amount of dread.

You arrive, usually fasting if anesthesia is planned. A nurse checks your identity, allergies and recent medicines. For prostate seeds or HDR, you will typically receive a general or spinal anesthetic; for some gynecologic HDR sessions, sedation or a regional block is used instead. Mayo Clinic describes applicator placement as the step requiring anesthesia, because thin needles, a catheter or an applicator must be positioned precisely.

Placement is guided by imaging. In prostate work, an ultrasound probe in the rectum shows the needles entering through the skin between the scrotum and anus. In cervical treatment, an applicator passes through the vagina into the cervix and uterus, sometimes secured with gauze packing. Afterward, a CT or MRI confirms position and the physics team finalizes the plan, which can take an hour or more while you rest.

Then the radiation. For HDR, the applicator connects to a machine that drives the source along the tube, pausing at planned points for seconds at a time; the whole delivery usually takes minutes, and you are alone in a shielded room with staff watching by camera and intercom. For permanent seeds, the seeds are implanted during the same anesthetic, and the procedure ends when the needles are withdrawn. For temporary LDR, you return to a private room with the sources in place and remain there until they are removed.

Recovery involves the usual post-anesthesia observation: monitoring, a drink, a walk to the bathroom. Many HDR and seed patients leave the same day; temporary LDR means an inpatient stay of a day or more, per Mayo Clinic.

Ask: Who will be in the room? Will I have a urinary catheter, and for how long? Who do I call tonight if something feels wrong?

How painful is brachytherapy, including for prostate cancer?

The honest answer is that the radiation itself does not hurt; the discomfort comes from applicators, needles and the body’s response to them, and it is usually manageable.

During placement you are anesthetized or sedated, so the procedure itself is not felt. Afterward, MedlinePlus and Mayo Clinic describe soreness or bruising in the perineum after prostate seed placement, a feeling of pressure or cramping with gynecologic applicators, and a burning sensation when passing urine for days to a couple of weeks. Blood in the urine or semen for a short period after prostate brachytherapy is common and expected.

If an applicator stays in place between HDR sessions, lying still for hours can be the hardest part. Centers manage this with positioning, pain relief and sometimes a temporary catheter so you do not need to move to urinate. Ask how long you will be immobile and what the plan is for comfort during that time.

Pain that escalates rather than settles is not the norm and should prompt a call. The treating team will tell you what over-the-counter or prescribed options are suitable for you; this is one of the places where a decision about any medicine belongs with the prescribing clinician, not a magazine.

Questions that help:

• What kind of discomfort should I expect on the day, and for how many days afterward?
• What pain relief will I be offered, and who adjusts it if it is not enough?
• Will I need a catheter, and how is it removed?
• What would you consider abnormal pain?

Most people describe the experience as uncomfortable rather than painful. That is a reasonable expectation, provided you tell the team early when something does not feel right.

Brachytherapy for cervical cancer: how many sessions, and what to ask

Cervical cancer is the setting where brachytherapy is least optional. For locally advanced disease, it is the step that delivers a high dose to the cervix after weeks of external beam radiotherapy and chemotherapy, and the National Cancer Institute describes it as a standard part of that treatment package.

How many sessions? There is no single number. HDR schedules are delivered in a short series of sessions, commonly spread over one to two weeks, and the exact count depends on the total dose the team has planned, the applicator used and how much external beam radiation preceded it. Some centers deliver two sessions in one applicator placement a day apart; others place the applicator fresh each visit. Ask for your specific number and the reasoning behind it, rather than comparing with another patient’s schedule.

The applicator may be intracavitary, sitting within the uterus and vagina, or combined with interstitial needles if the tumor extends sideways. MRI-guided planning is increasingly used so the dose wraps the tumor while sparing bladder and rectum.

Timing matters. Guidelines emphasize completing the full course of radiation, including brachytherapy, without long gaps, because prolonged overall treatment time has been associated with poorer control in cervical cancer. If a session is delayed by illness or logistics, ask how the team will adjust.

Questions to ask:

• How many brachytherapy sessions are planned, and over how many days?
• Will the applicator stay in between sessions, or be placed each time?
• What anesthesia or sedation will I have?
• How will you protect my bladder and bowel, and what symptoms should I expect from them?
• What is the plan for vaginal health afterward, including dilator use and sexual activity?

That last question is one patients rarely raise and clinicians sometimes forget. Raise it.

Brachytherapy side effects in the first weeks: what to ask

Early side effects are local, because the dose is local. They reflect inflammation of whatever tissue sits near the source, and they tend to peak in the first one to two weeks and settle over the following weeks, according to Mayo Clinic and MedlinePlus.

For prostate brachytherapy, the most common early complaints are urinary: frequency, urgency, a weak stream, burning and getting up at night. These happen because the urethra runs through the prostate and swells after needle placement and radiation. A small number of people cannot pass urine at all in the first days and need a temporary catheter. Bowel symptoms are usually milder early on.

For gynecologic brachytherapy, expect vaginal discharge, spotting, bladder irritation and sometimes loose stools or urgency. Fatigue is common across all sites and often reflects the cumulative effect of the whole treatment course rather than the brachytherapy alone.

For breast brachytherapy, redness, tenderness and bruising around the catheter sites are typical, with a small risk of infection or fluid collection.

Ask the team:

• Which early side effects are most likely for me, and roughly when do they peak and settle?
• What can I do at home to ease urinary or bowel irritation, and what should I avoid?
• Which symptoms mean I should call the same day?
• Will anyone check in with me by phone in the first week?

A note on medicines. Teams sometimes prescribe short courses to relax the bladder outlet or settle bowel symptoms. Those are decisions for the treating clinician, who knows your other medicines and conditions; do not start, stop or alter anything based on what another patient was given.

Early side effects are rarely dangerous, but they can be miserable if nobody warned you. Ask so that you are warned.

What are the long-term side effects of brachytherapy for prostate cancer?

Long-term effects are the ones that deserve the most airtime in your consultation, because they are the ones you live with.

For prostate brachytherapy, MedlinePlus and Mayo Clinic describe three categories. Urinary problems can persist or appear late: ongoing frequency or urgency, a narrowed urethra (stricture) that slows the stream, and, less commonly, leakage. Bowel changes include rectal irritation, urgency or occasional bleeding, reflecting the rectum’s position behind the prostate. Sexual function is the third: erectile difficulty can develop gradually over months to years as small blood vessels and nerves respond to radiation, and ejaculate volume typically falls.

How common is each? Published rates vary widely with technique, dose, patient age and baseline function, which is exactly why a general figure can mislead. The right question is “in patients like me, treated the way you treat them, how often do you see each of these, and how do you manage them?”

Two rarer long-term issues are worth asking about by name: a fistula (an abnormal channel between rectum and urethra), which is uncommon but serious, and a second cancer in the irradiated area many years later, which the National Cancer Institute lists as a small risk with any radiation.

For gynecologic brachytherapy, the equivalents are vaginal narrowing and dryness, bladder and bowel sensitivity, and effects on fertility and ovarian function when the ovaries are in or near the field. Dilator programs and pelvic floor physiotherapy are often recommended, and asking about them before treatment, not after, gives you the best chance of starting them early.

Ask, finally, what follow-up looks like for the long haul: which blood tests or scans, how often, and who to contact if a new symptom appears five years from now.

What precautions should I take during and after radiation therapy?

Precautions depend entirely on whether anything radioactive remains in your body.

After HDR brachytherapy, nothing does. The source is withdrawn, and the National Cancer Institute confirms you are not radioactive and need no special distance from others. The same is true of external beam radiotherapy.

After permanent seed brachytherapy, low-level radiation leaves the body in tiny amounts for a period that depends on the isotope’s half-life. MedlinePlus advises, as a general principle, limiting close and prolonged contact with pregnant women and young children for the time your team specifies, which is usually weeks to a couple of months. Brief contact, sharing a room, hugging and ordinary household life are generally fine. Some centers ask you to use a condom for a short time in case a seed is passed in semen, and to strain urine for the first days if a seed could be passed that way. You may be given a card explaining the implant in case a security scanner detects it.

During temporary LDR treatment, you remain in a shielded room and visitors are limited; staff will explain the rules.

Other practical precautions apply regardless of method:

• Keep skin near catheter or needle sites clean and dry until it heals.
• Stay hydrated to ease urinary irritation, unless advised otherwise.
• Tell any other doctor or dentist you have had internal radiation.
• Keep follow-up appointments even if you feel well.

Ask your team for written instructions that name specific durations for your isotope and your situation. “A few weeks” is not enough when a grandchild is due to visit; ask for the actual date your precautions end.

What the following days and weeks usually look like

The first 24 hours are about anesthesia wearing off and watching that you can pass urine. If a catheter was placed, it is usually removed before you go home or within a day or two. Expect grogginess, some bruising and a general sense that your pelvis has been busy.

Days two to seven are the irritable stretch. Urinary burning, frequency and urgency build; vaginal discharge or spotting continues after gynecologic treatment; fatigue is real. Mayo Clinic suggests most people return to light daily activity within a few days, though heavy lifting and vigorous exercise are usually paused for a short period your team will define.

Weeks two to four are typically the peak and then the turn. Symptoms often reach their worst around this window and then begin easing, according to MedlinePlus guidance for prostate seeds. Sexual activity can usually resume once soreness and any seed-passage precautions have ended, which is a question for your team rather than a date to assume.

Weeks six to twelve bring the first formal review. For prostate cancer, a PSA blood test provides a baseline; readings fall gradually over months rather than dropping at once, and a temporary rise, sometimes called a bounce, can occur after brachytherapy without meaning the cancer has returned. For cervical cancer, imaging and examination are scheduled to assess response.

The following months are about long-term monitoring and managing anything that lingers.

Ask: When can I drive, lift, exercise, swim, have sex and return to work? What is the follow-up schedule for the first year? Who is my named contact if something changes between visits?

Timelines here are typical ranges drawn from the references above, not promises. Your own course will depend on your anatomy, your method and what else your treatment plan includes.

What people often get wrong about brachytherapy

Several myths travel well because they contain a grain of truth.

“I’ll be radioactive and dangerous to my family.” After HDR, you are not radioactive at all. After permanent seeds, the radiation that reaches others is small and fades; the National Cancer Institute and MedlinePlus describe sensible, time-limited precautions for pregnant women and small children, not isolation. Nobody needs to sleep in a separate house.

“Brachytherapy is the gentle option, so it has no real side effects.” The dose to the tumor is high, and the tissues next door feel it. Urinary, bowel and sexual effects are real; the difference is that they are local and that distant organs are largely spared.

“It’s a one-and-done procedure.” Sometimes, with permanent seeds. Often, with HDR, it is a series of sessions, and in cervical cancer it follows weeks of external beam therapy. Ask what the whole plan looks like, not just the brachytherapy piece.

“The seeds will set off airport scanners and need to be removed.” Seeds are permanent and inert within weeks to months; a card from your center explains the implant if a sensitive detector picks it up.

“A rising PSA after seeds means it has failed.” A temporary PSA rise can occur in the months after brachytherapy and settle again. Interpretation belongs to your team, who will look at the trend, not a single number.

“It’s experimental.” Brachytherapy has been used for more than a century and is a guideline-standard treatment for several cancers. What has changed is image-guided planning, which is more precise than older techniques.

“Newer always means better.” Newer techniques exist for every modality. Ask what the evidence shows for your situation rather than assuming the latest machine or method is the right one.

Questions to ask your care team: a printable list

Bring this list, cross out what has been answered, and add your own. You do not need to ask all of it in one visit; many centers offer a nurse consultation or a follow-up call for the rest.

About fit and alternatives:

• Why brachytherapy for my cancer and stage? What would have made you suggest something else?
• What are my alternatives, including no immediate treatment, and how do their side effects compare?
• Is this the whole plan or a boost alongside external beam, hormonal therapy or surgery?

About the procedure:

• HDR or LDR, and why? If seeds, which isotope and how long do precautions last?
• How many sessions, over what period, and will applicators stay in between?
• What anesthesia will I have, and will I stay overnight?
• Will I need a catheter, and for how long?

About side effects:

• Which early effects are most likely for me, and when do they peak and settle?
• Which long-term effects do you see most in patients like me, and how are they managed?
• Is there anything I can start now, such as pelvic floor exercises or a dilator plan, to reduce later problems?

About logistics and follow-up:

• When can I drive, work, exercise and have sex?
• What follow-up tests will I have, how often, and what do the results mean?
• Who do I call out of hours, and what symptoms warrant a call?
• Are you comfortable with me seeking a second opinion?

A final question that rarely fails: “What do your patients most wish they had known before this treatment?” Experienced clinicians have heard the regrets and the relief many times over, and their answer is often the most useful thing you take home.

When to call your doctor

Most people get through brachytherapy with discomfort that follows the expected arc. A few develop problems that need prompt attention, and the difference between a manageable complication and a serious one is often how quickly it is reported. Contact your treatment team or seek urgent care if you notice any of the following, drawn from Mayo Clinic, MedlinePlus and NHS guidance on radiotherapy:

• You cannot pass urine for several hours despite feeling the urge, or your bladder feels painfully full. This can signal urinary retention and may need a catheter.
• Fever, chills or shaking, which may indicate infection at a needle or catheter site or in the urinary tract.
• Heavy bleeding from the urethra, rectum or vagina, or bleeding that does not slow after a short time, rather than the light spotting that is expected.
• Severe or worsening pelvic, abdominal or perineal pain that pain relief does not touch.
• Redness, swelling, warmth or discharge spreading around a catheter or implant site.
• Persistent vomiting, inability to keep fluids down, or signs of dehydration such as dizziness and very dark urine.
• Calf pain, swelling of one leg, sudden breathlessness or chest pain, which can be signs of a blood clot after a procedure and immobility.
• Passing stool through the vagina or urine mixed with stool, which can indicate a fistula and needs same-day assessment.
• A seed found in urine or ejaculate, which is usually harmless but should be reported and handled as your center instructed.

You should also call if side effects are simply worse than you were told to expect, or if they are not improving by the time you were told they would. “Is this normal?” is a legitimate reason to phone, and no reasonable team will mind.

Keep the out-of-hours number somewhere you will find it at two in the morning. Decisions about what to do next belong with your treating team, who know your plan and your history.

Frequently asked questions

What are the most important questions to ask about brachytherapy?

Ask why brachytherapy suits your cancer and stage, whether the plan is high dose rate or low dose rate, how many sessions are involved, what anesthesia you will have, which early and long-term side effects are most likely for you, what precautions apply afterward, how results will be monitored, and what the alternatives are. Write down the answers and ask who to call if problems arise.

How does brachytherapy work compared with external beam radiotherapy?

Brachytherapy delivers radiation from a source placed inside or next to the tumor, so the dose is highest at the cancer and drops steeply a short distance away. External beam radiotherapy aims radiation through the body from a machine over many daily sessions. Both are established treatments; which one suits you depends on cancer type, tumor position and your overall plan.

What is the difference between HDR vs LDR brachytherapy?

High dose rate (HDR) uses a strong source delivered for minutes per session and then withdrawn, leaving nothing radioactive behind. Low dose rate (LDR) uses weaker sources that stay in place for hours or days, or permanent seeds that decay over weeks to months. Both are standard; the choice depends on cancer type, anatomy and the center’s expertise.

How painful is brachytherapy for prostate cancer?

The radiation itself is painless. Needle placement is done under general or spinal anesthesia, and afterward most people describe soreness or bruising in the perineum, burning when urinating and some blood in urine or semen for days to a couple of weeks. Pain that escalates rather than settles is not typical and should be reported to your team promptly.

What are the long-term side effects of brachytherapy for prostate cancer?

The main long-term concerns are urinary problems such as ongoing frequency, a narrowed urethra or leakage; bowel irritation or occasional rectal bleeding; and erectile difficulty that can develop gradually over months to years. Rarer effects include a fistula between rectum and urethra and a small risk of a second cancer years later. Rates vary with technique and patient factors, so ask for figures specific to your situation.

How many sessions of brachytherapy for cervical cancer are usual?

There is no universal number. Cervical brachytherapy is typically delivered as a short series of high dose rate sessions over one to two weeks after external beam radiotherapy and chemotherapy. The exact count depends on the planned total dose and the applicator used. Guidelines emphasize completing the full course without long gaps, so ask your team for your specific schedule and reasoning.

What precautions should I take during radiation therapy with permanent seeds?

After permanent seed implants, limit close and prolonged contact with pregnant women and young children for the period your team specifies, usually weeks to a couple of months depending on the isotope. Ordinary household contact is generally fine. You may be asked to use a condom briefly and to carry a card explaining the implant. After HDR or external beam treatment, no radiation precautions are needed.

What brachytherapy side effects should I expect in the first weeks?

Early effects are local and usually peak within the first one to two weeks before settling. Prostate treatment commonly causes urinary frequency, urgency, burning and a weak stream; gynecologic treatment causes vaginal discharge, spotting and bladder or bowel irritation; breast treatment causes redness and tenderness at catheter sites. Fatigue is common across all sites. Ask which symptoms warrant a same-day call.

Is brachytherapy right for me, or should I consider other options?

That depends on your cancer type, stage, tumor position, anatomy and the side effects you are most willing to accept. For localized prostate cancer several options are considered appropriate, and for locally advanced cervical cancer brachytherapy is a standard part of treatment. A second opinion is reasonable, and the final decision should be made with your treating team.

Can I ask my radiation oncologist for a second opinion on brachytherapy?

Yes, and a good oncologist will not be offended. Second opinions are routine in cancer care, particularly when more than one reasonable treatment exists. Ask whether your imaging, pathology and planning notes can be shared, and whether the alternative center offers methods yours does not. Comparing recommendations can clarify why one approach is being proposed for you.

References

• MedlinePlus: Prostate brachytherapy
• NHS: Radiotherapy
• NHS: Prostate cancer treatment

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.